Niagen Bioscience Inc (NAGE)

EBITDA Growth

-71.41%

Quarterly · Period ending:

NAGE logo

NAGE EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-71.41%
NAGE Quarterly EBITDA YoY % (-21410.38% → -71.41%)
High-resolution chart · PNG

NAGE ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Niagen Bioscience Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-71.4076%
28.5765%
-38.8931%
129.902%
1,052.6761%
5,589.2157%
1,510.2669%
539.1389%
120.3205%
93.0233%
115.8426%
3.7665%
70.6682%
79.6464%
37.6218%
93.6973%
-15.898%
-3.2782%
13.331%
-120.6075%
-55.0694%
-25.9507%
33.1295%
41.1193%
51.1786%
30.975%
-6.1681%
22.4904%
12.2204%
2.6764%
6.9332%
-180.2411%
-215.7615%
-407.4074%
-329.9322%
-262.1927%
-615.4715%
-395.2557%
-73.8624%
-414.3341%
562.9647%
166.2381%
-11.6534%
144.971%
93.4932%
53.4529%
-58.8051%
50.6612%
-65.6637%
-33.5882%
59.5207%
18.2655%
75.6%
69.2687%
32.8247%
37.0541%
-125.2183%
-313.7749%
-202.2422%
-196.7551%
-777.9112%
-894.5943%
-6,105.0738%
-911.2234%
-5.1714%
159.5744%
97.5854%
87.3112%
70.0252%
-14,774.1608%
-13,925.7787%
-21,410.378%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.